Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neurocrine Bioscienc (NBIX)

Neurocrine Bioscienc (NBIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,210,856
  • Shares Outstanding, K 93,429
  • Annual Sales, $ 788,090 K
  • Annual Income, $ 37,010 K
  • 60-Month Beta 1.01
  • Price/Sales 10.26
  • Price/Cash Flow 158.60
  • Price/Book 13.02
Trade NBIX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.61
  • Number of Estimates 11
  • High Estimate 0.93
  • Low Estimate 0.16
  • Prior Year 0.35
  • Growth Rate Est. (year over year) +74.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.71 +16.57%
on 01/04/21
113.40 -4.70%
on 01/13/21
+12.75 (+13.38%)
since 12/15/20
3-Month
86.02 +25.64%
on 11/19/20
113.40 -4.70%
on 01/13/21
+8.24 (+8.26%)
since 10/15/20
52-Week
72.14 +49.81%
on 03/18/20
136.26 -20.69%
on 07/09/20
+0.71 (+0.67%)
since 01/15/20

Most Recent Stories

More News
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today provided an update on its business performance, including preliminary net product and inventory adjusted sales results of INGREZZA...

JPM : 139.07 (-1.49%)
NBIX : 108.04 (-1.14%)
Neurocrine Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 39 Annual J.P. Morgan Healthcare Conference at Jan. 11, 2021. , Chief Executive Officer, will present at the conference....

JPM : 139.07 (-1.49%)
NBIX : 108.04 (-1.14%)
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

Voyager Therapeutics, Inc. (Nasdaq: VYGR) today announced that the U.S. Food and Drug Administration (FDA) has notified Neurocrine Biosciences (Nasdaq: NBIX) that it has placed a clinical hold on the RESTORE-1...

VYGR : 8.59 (-3.70%)
NBIX : 108.04 (-1.14%)
Women Health Market Size Business Growth, Global Market Analysis, Share, Research, and Forecast to 2025 Research Reports World

Posted on Dec 14 2020 10:01 AM

ABT : 111.07 (+0.94%)
AGN : 193.02 (+0.02%)
AMGN : 246.46 (+1.99%)
AZN : 51.35 (+0.12%)
BAYRY : 15.8500 (-1.18%)
LLY : 191.27 (+2.45%)
GSK : 38.42 (+0.68%)
NBIX : 108.04 (-1.14%)
NVS : 95.61 (+1.05%)
NOVN : 1.2900 (+29.00%)
NVO : 72.05 (+1.44%)
PFE : 36.71 (-0.11%)
RDUS : 21.69 (-3.73%)
TXMD : 1.4089 (-2.16%)
VRX.TO : 30.80 (-3.33%)
New Strong Sell Stocks for December 9th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

NBIX : 108.04 (-1.14%)
NBEV : 2.96 (-1.66%)
FENC : 7.55 (+2.17%)
SLDB : 6.59 (+2.01%)
GHG : 13.07 (+0.31%)
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Neurocrine Biosciences management will present at the following investor conferences:

NBIX : 108.04 (-1.14%)
Neurocrine Biosciences Announces Repurchase of Convertible Notes

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the Company has entered into separate, privately negotiated transactions (the "Agreements") with certain holders of...

NBIX : 108.04 (-1.14%)
Neurocrine Biosciences (NBIX) Reports Q3 Loss, Lags Revenue Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of -663.64% and -8.31%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

NBIX : 108.04 (-1.14%)
Neurocrine: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported a third-quarter loss of $57.6 million, after reporting a profit in the same period a year earlier.

NBIX : 108.04 (-1.14%)
Neurocrine Biosciences Reports Third Quarter 2020 Financial Results

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended and provided revised full-year 2020 financial expense guidance.

NBIX : 108.04 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding...

See More

Key Turning Points

3rd Resistance Point 115.49
2nd Resistance Point 112.94
1st Resistance Point 111.11
Last Price 108.15
1st Support Level 106.73
2nd Support Level 104.18
3rd Support Level 102.35

See More

52-Week High 136.26
Fibonacci 61.8% 111.77
Last Price 108.15
Fibonacci 50% 104.20
Fibonacci 38.2% 96.64
52-Week Low 72.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar